Email ID
Sign me in automatically next time
First Hep C protease head-to-head trial pits Medivir's TMC435 against J&J's telaprevir

In what is the first of its kind – and might well be the last - the protease inhibitor drug TMC435 developed by J&J unit Janssen Pharmaceuticals in collaboration with Swedish...
14 March 2012
John Hodgson

Please Login to read the full article.
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36